Defects of cholecystokinin (CCK)-A receptor gene expression and CCK-A receptor-mediated biological functions in Otsuka Long-Evans Tokushima Fatty (OLETF) rats

Journal of Gastroenterology

Volumn 33, Issue 5, 1998, Pages 702-709

  Nakamura, Hayato ^a   Kihara, Yasuyuki ^a   Tashiro, Mitsuo ^a   Kanagawa, Kenji ^a   Shirohara, Hisashi ^a   Yamamoto, Mitsuyoshi ^a   Yoshikawa, Hiroyuki ^a   Fukumitsu, Ken Ichiro ^a   Hirohata, Yoshihide ^a   Otsuki, Makoto ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

CCK A receptor mediated function; CCK Aa receptor; OLETF rat

Indexed keywords

CARBACHOL; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ B RECEPTOR; PEPSINOGEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BRAIN; CONTROLLED STUDY; FOOD INTAKE; GENE EXPRESSION; NONHUMAN; PANCREAS; PRIORITY JOURNAL; RAT; RECEPTOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; STOMACH;

ANIMALS; ARGININE; BLOOD GLUCOSE; BLOTTING, NORTHERN; BLOTTING, SOUTHERN; BRAIN; CARBACHOL; DNA PRIMERS; GASTRIC ACID; GENE EXPRESSION; INSULIN; MALE; OBESITY; PANCREATIN; PEPSINOGEN A; RATS; RATS, LONG-EVANS; RATS, WISTAR; RECEPTOR, CHOLECYSTOKININ A; RECEPTORS, CHOLECYSTOKININ; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SINCALIDE; STOMACH;

EID: 7344221520     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350050158     Document Type: Article

References (33)

1. Kawano K, Hirashima T, Mori S, et al. Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes 1992;41:1422-1428.
2. Funakoshi A, Miyasaka K, Jimi A, et al. Little or no expression of the cholecystokinin-A receptor gene in the pancreas of diabetic rats (Otsuka Long-Evans Tokushima Fatty = OLETF rats). Biochem Biophys Res Commun 1994;199:482-488.
3. Tachibana I, Akiyama T, Kanagawa K, et al. Defect in pancreatic exocrine and endocrine response to CCK in genetically diabetic OLETF rats. Am J Physiol 1996;270:G730-737.
4. Otsuki M, Akiyama A, Shirohara H, et al. Loss of sensitivity to cholecystokinin stimulation of isolated pancreatic acini from genetically diabetic rats. Am J Physiol 1995;268:E531-536.
5. Liddle RA. Integrated action of cholecystokinin on the gastrointestinal tract: Use of the cholecystokinin bioassay. Gastroenterol Clin North Am 1989;18:735-756.
6. Sakamoto C, Goldfine ID, Roach E, et al. Localization of saturable CCK binding sites in rat pancreatic islets by light and electron microscope autoradiography. Diabetes 1985;34:390-394.
7. Jensen RT, Wank SA, Rowley WH, et al. Interaction of CCK with pancreatic acinar cells. Trends Pharmacol Sci 1989;10:418-423.
8. Wank S, Piseagna JR, de Weerth A. Cholecystokinin receptor family. Molecular cloning, structure and functional expression in rat, guinea pig and human. Ann N Y Acad Sci 1994;713:49-66.
9. Wank S, Harkins R, Jensen RT, et al. Purification, molecular cloning, and functional expression of the cholecystokinin receptor from rat pancreas. Proc Natl Acad Sci USA 1992;89:3125-3129.
10. de Weerth A, Pisegna J, Huppi K, et al. Molecular cloning, functional expression and chromosomal localization of the human cholecystokinin type A receptor. Biochem Biophys Res Commun 1993;194:811-818.
11. Wank S, Pisegna J, de Weerth A. Brain and gastrointestinal cholecystokinin receptor family: Structure and functional expression. Proc Natl Acad Sci USA 1992;89:8691-8695.
12. Pisegna J, de Weerth A, Huppi K, et al. Molecular cloning of the human brain and gastric cholecystokinin receptor: Structure, functional expression and chromosomal localization. Biochem Biophys Res Commun 1992;189:296-303.
13. Wank S. Cholecystokinin receptors. Am J Physiol 1995; 269:0628-646.
14. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
15. Otsuki M, Sakamoto C, Yuu H, et al. Discrepancies between the doses of cholecystokinin or caerulein-stimulating exocrine and endocrine responses in perfused isolated rat pancreas. J Clin Invest 1979;63:478-484.
16. Otsuki M, Okabayashi Y, Ohki A, et al. Action of cholecystokinin analogues on exocrine and endocrine rat pancreas. Am J Physiol 1986;250:G405-411.
17. Niida H, Takeuchi K, Okabe S. Role of thyrotropine-releasing hormone in acid secretory response induced by lowering of body temperature in the rat. Eur J Pharmacol 1991;198:137-142.
18. Tachibana I, Watanabe N, Shirohara H, et al. Effects of tetraprenylacetone on pancreatic exocrine secretion and acute pancreatitis in two experimental models in rats. Int J Pancreatol 1995;17:147-154.
19. Lowry OH, Rosebrouh NJ, Farr AL, et al. Protein measurement with Folin phenol reagent. J Biol Chem 1951;193:265-275.
20. Anson ML, Mirsky AE. The estimation of pepsin with hemoglobin. J Gen Physiol 1932;16:59-63.
21. Otsuki M, Sakamoto C, Maeda M, et al. Effect of caerulein on exocrine and endocrine pancreas hi the rat. Endocrinology 1980;105:1396-1399.
22. Sakamoto C, Otsuki M, Ohki A, et al. Glucose-dependent insulinotropic action of cholecystokinin and caerulein in the isolated perfused rat pancreas. Endocrinology 1982;110:398-402.
23. Okabayashi Y, Otsuki M, Nakamura T, et al. Proglumide analogues CR 1409 and CR 1392 inhibit cholecystokinin-stimulated insulin release more potently than exocrine secretion from the isolated perfused rat pancreas. Pancreas 1990;5:291-297.
24. Jebbink MCW, Lamers CBHW, Mooy DM, et al. Effect of loxiglumide on basal and gastrin- and bombesin-stimulated gastric acid and gastrin levels. Gastroenterology 1992;103:1215-1220.
25. Schbert ML, Makhlouf GM. Neural and paracrine regulation of gastrin and gastric acid secretion. Gastroenterology 1996;111: 837-838.
26. Schmidt WE, Schnek S, Nustede R, et al. Cholecystokinin is a negative regulator of gastric acid secretion and postprandial release of gastrin in humans. Gastroenterology 1994;107:1610-1620.
27. Lee Y-M, Beinborn M, McBride EW, et al. The human brain cholecystokinin-B/gastrin receptor. Cloning and characterization. J Biol Chem 1993;268:8164-8169.
28. Hewson G, Leighton GE, Hill RG, et al. The cholecystokinin receptor antagonist L364,718 increases food intake in the rat by attenuation of the action of endogenous cholecystokinin. Br J Pharmacol 1988;93:79-34.
29. Reidelberger RD, O'Rourke MF. Potent cholecystokinin antagonist L 364-718 stimulates food intake in rats. Am J Physiol 1989;257:R1512-1518.
30. Corwin RL, Gibbs J, Smith GP. Increased food intake after type A but not type B cholecystokinin receptor blockade. Physiol Behav 1991;50:255-258.
31. Hirosue Y, Inui A, Teranishi A, et al. Cholecystokinin octapeptide analogues suppress food intake via central CCK-A receptors in mice. Am J Physiol 1993;265:R481-486.
32. Smith GP, Tyrka A, Gibbs J. Type-A CCK receptors mediate the inhibition of food intake and activity by CCK-8 in 9- to 12-day-old rat pups. Pharmacol Biochem Behav 1991;38:207-210.
33. Moran TH, Ameglio PJ, Schwartz GJ, et al. Blockade of type A, not type B receptors attenuates satiety actions of exogenous and endogenous CCK. Am J Physiol 1992;262:R46-50.